Europe Corneal Transplant Market
市场规模（十亿美元）
CAGR :
% 
 Forecast Period |
2024 –2031 |
 Market Size (Base Year) |
USD 100.54 Million |
 Market Size (Forecast Year) |
USD 155.95 Million |
 CAGR |
% |
| Major Markets Players |
欧洲角膜移植市场，按手术类型（内皮角膜移植术、穿透性角膜移植术、前板层角膜移植术 (ALK)、角膜缘干细胞移植、人工角膜移植等）、类型（人角膜和合成角膜）、供体类型（自体移植和同种异体移植）、移植类型（部分厚度移植（板层）和全厚度移植（穿透））、手术类型（常规手术、激光辅助手术）、适应症（Fuch 内皮营养不良、传染性角膜炎、大疱性角膜病变、圆锥角膜、再移植手术、角膜瘢痕、角膜溃疡等）、性别（女性和男性）、年龄组（老年、成人和儿童）、最终用户（医院、眼科诊所、门诊手术中心、学术和研究机构等）划分。其他）- 行业趋势及 2031 年预测
欧洲角膜移植市场分析及规模
欧洲角膜植入物市场受到多种因素的推动，包括角膜疾病患病率的不断上升、人口老龄化加剧、技术进步、对微创手术的需求不断增长、对角膜移植的认识不断提高、政府举措和资金、混合型和散光型晶状体的采用率不断提高、交联手术越来越受欢迎、角膜植入物适应症的不断扩大以及促进创新的竞争环境。这些因素共同推动了对角膜植入物的需求，尤其是在发达国家，因为患者寻求对视力障碍和圆锥角膜、福克斯营养不良和人工晶状体大泡性角膜病变等疾病的有效治疗。
Data Bridge Market Research 分析称，欧洲角膜移植市场规模预计将从 2023 年的 1.0054 亿美元增至 2031 年的 1.5595 亿美元，在 2024 年至 2031 年的预测期内，复合年增长率为 5.7%。
|
报告指标 |
细节 |
|
预测期 |
2024 至 2031 年 |
|
基准年 |
2023 |
|
历史岁月 |
2022（可定制 2016-2021） |
|
定量单位 |
收入（百万美元） |
|
涵盖的领域 |
手术类型（内皮角膜移植术、穿透性角膜移植术、前板层角膜移植术 (ALK)、角膜缘干细胞移植、人工角膜移植等）、类型（人角膜和合成角膜）、供体类型（自体移植和同种异体移植）、移植类型（部分厚度移植（板层）和全厚度移植（穿透））、手术类型（常规手术、激光辅助手术）、适应症（Fuch 内皮营养不良、感染性角膜炎、大疱性角膜病变、圆锥角膜、再移植手术、角膜瘢痕、角膜溃疡等）、性别（女性和男性）、年龄组（老年人、成年人和儿童）、最终用户（医院、眼科诊所、门诊手术中心、学术和研究机构等） |
|
覆盖国家 |
德国、法国、英国、意大利、西班牙、俄罗斯、荷兰、瑞士、土耳其、比利时、丹麦、挪威、瑞典、波兰、欧洲其他地区 |
|
涵盖的市场参与者 |
蔡司集团 (Carl Zeiss Meditec AG.)、爱尔康、CorneaGen、Ziemer Ophthalmic Systems AG、RUMEX International Co. 等。 |
市场定义
角膜移植市场是指专注于用健康供体组织替换受损或患病角膜的外科手术的医疗领域。角膜移植，也称为角膜移植术，用于恢复患有圆锥角膜、角膜瘢痕、感染或角膜内皮功能障碍等疾病的患者的视力。该市场涵盖各种类型的移植手术，包括穿透性角膜移植术（全层角膜移植）和内皮角膜移植术（部分层角膜移植），并受到手术技术进步、供体组织可用性和术后护理改善的支持。随着眼部疾病在全球范围内变得越来越普遍，以及技术创新提高了手术的成功率，角膜移植市场持续增长，满足了对视力恢复日益增长的需求。
欧洲角膜移植市场动态：
本节旨在了解市场驱动因素、优势、机遇、限制和挑战。以下内容将详细讨论所有这些内容：
驱动程序
- 眼部疾病发病率不断上升
眼部疾病的日益流行是欧洲角膜移植市场的重要推动因素，因为圆锥角膜、福克斯角膜内皮营养不良症以及因感染或创伤导致的角膜瘢痕等疾病正变得越来越普遍。这些疾病可能导致严重的视力障碍或失明，从而促使人们对角膜移植作为修复治疗的需求不断增长。眼部疾病的增加通常与人口老龄化、糖尿病发病率上升以及接触环境污染物和紫外线辐射增加等因素有关，这些因素可能会损害角膜。此外，诊断技术的进步使人们能够更早地发现这些疾病，从而及时进行干预，包括角膜移植。此外，人们对角膜健康的认识不断提高，以及改进的手术技术（如 Descemet 膜内皮角膜移植术 (DMEK) 和 Descemet 剥离自动内皮角膜移植术 (DSAEK)）的出现，也促使人们越来越多地接受角膜移植。随着全球眼部疾病负担不断增加，对角膜移植等有效解决方案的需求预计将增加，从而推动市场增长。
例如，
- 2023 年 6 月，根据 NCBI 发表的文章，进行了一项研究，以调查德国大型队列中圆锥角膜的患病率并评估可能的相关因素。圆锥角膜似乎是一种罕见的角膜疾病，患病率此前估计为 1:2000。然而，在最近相对较小的研究中，发现患病率更高。据报道，美国公民的患病率为 1:6000，以色列青少年的患病率为 1:1000，沙特阿拉伯儿童的患病率为 1:20。较新的研究发现，新西兰高中生的患病率估计为 1:191。在澳大利亚年轻人中，患病率高达 1:84。德国人口中圆锥角膜治疗的患病率比文献中之前使用最新技术（即 Scheimpflug 成像）报道的患病率高出约十倍，这成为市场增长的驱动力。
老年人口不断增加
老年人口的增加是欧洲角膜移植市场的主要驱动力，因为老年人更容易患上各种眼部疾病，这些疾病可能导致角膜损伤和需要移植。与年龄相关的眼部疾病，如福克斯内皮营养不良症、大泡性角膜病变和其他退行性角膜疾病，随着年龄的增长而变得更加普遍，大大增加了对角膜移植的需求。此外，老年人更容易出现白内障手术并发症或患上糖尿病等慢性疾病，这会进一步加剧角膜恶化。随着欧洲人口老龄化，需要角膜移植的人数预计将增加，特别是在人口老龄化迅速的地区。随着人们对角膜移植的可用性和成功率的认识不断提高，以及手术技术的进步为老年患者提供更好的结果和更快的恢复时间，这一趋势进一步加剧。因此，老年人口的增长是推动欧洲角膜移植市场扩张的主要因素，凸显了对与年龄相关的角膜疾病的可获得且有效的治疗方案的需求。
机会
- 医疗基础设施建设
医疗基础设施的改善为欧洲角膜移植市场提供了重大机遇，扩大了移植服务的可及性。基础设施的改善促成了更多医院和专科诊所的建立，使更多人能够接受角膜移植。医疗资源匮乏或农村地区的设施改善确保了以前无法获得专科眼科护理的患者现在可以接受基本的移植服务。
现代化的医疗机构配备了先进的手术技术和诊断工具，这直接提高了角膜移植的成功率并最大限度地减少了并发症。这些先进系统内的专业中心提供有针对性的专业知识和资源，进一步提高了手术效果和患者护理。这些设施的容量增加还支持更多的移植手术，有效地满足了患者的需求并减少了等待时间。
例如，
- 2024 年 4 月，根据《医院基础设施的兴起和现代化更新》一文，美国拥有强大的医疗基础设施，包括 6,000 多所医院和数千家小型诊所，为患者提供超过一百万张病床。这些基础设施包括各种基本要素，例如先进的研究实验室、尖端技术和各种医疗设备。此外，联邦政府一直在为该国医疗基础设施的持续现代化提供资金
- 2023 年 8 月，据 JLL India 称，印度一直在欢迎更多投资和创新，以应对未来危及生命的疾病和流行病，这反过来又有助于该国医疗保健和生命科学领域的发展
克制/挑战
- 角膜移植手术费用高昂
角膜移植手术的高昂费用严重制约了欧洲角膜移植市场的增长，限制了患者的可及性和可负担性，尤其是在中低收入国家。角膜移植手术，包括传统的穿透性角膜移植术 (PK) 和先进的技术，如 Descemet 膜内皮角膜移植术 (DMEK) 或 Descemet 剥离自动内皮角膜移植术 (DSAEK)，通常不仅需要大量手术费用，还需要术前评估、术后护理、药物和随访相关费用。此外，获取捐赠角膜的成本，无论是通过眼库还是商业来源，都进一步加重了经济负担。在许多地区，特别是医疗基础设施有限的地区，这些成本因缺乏保险覆盖或报销政策不充分而加剧，使得很大一部分人无力承担角膜移植的费用。此外，对专业手术专业知识和先进设备的需求增加了总体费用，从而限制了这些手术仅在城市地区设备齐全的医疗中心进行。因此，角膜移植手术的高成本阻碍了市场增长，减少了潜在的患者数量，特别是在医疗资源匮乏的地区，这些地区的角膜疾病负担往往最重，获得负担得起的医疗服务的机会有限。
最新动态
- 2024 年 1 月，卡尔蔡司印度医疗技术部门在班加罗尔 Nethradhama Super Speciality 举办的 Phaco Festival 上展示了白内障和屈光手术工作流程。在 Phaco Festival 上，蔡司对白内障和角膜屈光手术工作流程的变革性影响备受关注。
- 2024 年 6 月，CorneaGen 今天宣布推出角膜移植术用角膜组织添加 (CTAK)，这是一种创新且极为有效的圆锥角膜眼角膜轮廓解决方案。CTAK 由 CorneaGen 与 CTAK LLC 和 Ziemer 合作开发，可提供患者可用、经伽马射线照射的无菌、无免疫原性的角膜组织片段，这些片段经过激光切割并根据患者特定的圆锥严重程度和位置进行定制
- 2024 年 1 月，总部位于西雅图的 CorneaGen 很高兴地宣布，其眼部恢复服务将扩展到加利福尼亚州北部和南部。通过此次服务扩展，CorneaGen 现在将为全州的机构提供眼部恢复和捐献组织处理服务，从而为其加利福尼亚州合作机构的患者、家属和员工带来更好的体验。
- 2024 年 8 月，蔡司延续其在全球屈光行业的势头，超过 1000 万只眼睛接受了蔡司 SMILE 和蔡司 SMILE pro 治疗；蔡司宣布在消费电子市场首次采用蔡司 SMILE pro 技术进行透镜提取治疗远视
欧洲角膜移植市场范围
欧洲角膜移植市场根据手术类型、类型、供体类型、移植类型、手术类型、适应症、性别、年龄组和最终用户分为八个显著的细分市场。细分市场之间的增长有助于您分析利基增长领域和进入市场的策略，并确定您的核心应用领域和目标市场的差异。
程序类型
- 内皮角膜移植术
- 穿透性角膜移植术
- 前板层角膜移植术 (ALK)
- 角膜缘干细胞移植
- 人工角膜移植
- 其他的
根据手术类型，市场分为内皮角膜移植术、穿透性角膜移植术、前板层角膜移植术 (ALK)、角膜缘干细胞移植、人工角膜移植等。
类型
- 人类角膜
- 合成的
根据类型，市场分为人类角膜和合成角膜。
供体类型
- 同种异体移植
- 自体移植
根据捐赠者类型，市场分为同种异体移植和自体移植。
移植物类型
- 部分厚度移植（层状）
- 全层移植（穿透性）
根据移植类型，市场分为部分厚度移植（板层）、全厚度移植（穿透）。
手术类型
- 传统手术
- 激光辅助手术
根据手术类型，市场分为传统手术和激光辅助手术。
指征
- 福克斯内皮营养不良症
- 传染性角膜炎
- 大泡性角膜病变
- 圆锥角膜
- 再移植程序
- 角膜瘢痕
- 角膜溃疡
- 其他的
根据适应症，市场分为福克斯角膜内皮营养不良症、传染性角膜炎、大泡性角膜病变、圆锥角膜、再移植手术、角膜瘢痕、角膜溃疡等。
性别
- 女性
- 男性
根据性别，市场分为女性和男性。
年龄组
- 老年
- 成人
- 儿科
根据年龄组，市场分为老年人、成年人和儿童。
最终用户
- 医院，
- 眼科诊所，
- 门诊手术中心，
- 学术及研究机构
- 其他的
根据最终用户，市场分为医院、眼科诊所、门诊手术中心、学术和研究机构等。
欧洲角膜移植市场区域分析/见解
对欧洲角膜移植市场进行了分析，并根据上述手术类型、类型、捐赠者类型、移植类型、手术类型、适应症、性别、年龄组和最终用户提供了市场规模洞察和趋势。
本市场报告涵盖的国家包括德国、法国、英国、意大利、西班牙、俄罗斯、荷兰、瑞士、土耳其、比利时、丹麦、挪威、瑞典、波兰、欧洲其他地区。
德国预计将在欧洲市场占据主导地位，因为它拥有先进的医疗保健基础设施、巨大的眼部治疗消费者需求、强大的制药业、广泛的研发力度以及完善的分销网络，是创新中心。
报告的国家部分还提供了影响市场当前和未来趋势的各个市场影响因素和市场监管变化。下游和上游价值链分析、技术趋势和波特五力分析、案例研究等数据点是用于预测各个国家市场情景的一些指标。此外，在提供国家数据的预测分析时，还考虑了区域品牌的存在和可用性以及它们因来自本地和国内品牌的大量或稀缺竞争而面临的挑战、国内关税和贸易路线的影响。
竞争格局和欧洲角膜移植市场份额分析
欧洲角膜移植市场根据手术类型、捐赠者类型、移植类型、手术类型、适应症、性别、年龄组和最终用户分为八个显著的部分。
欧洲角膜移植市场竞争格局按竞争对手提供详细信息。详细信息包括公司概况、公司财务状况、收入、市场潜力、研发投资、新市场计划、区域存在、生产基地和设施、生产能力、公司优势和劣势、产品发布、产品宽度和广度以及应用主导地位。以上提供的数据点仅与公司对欧洲角膜移植市场的关注有关。
欧洲角膜移植市场的一些主要参与者包括蔡司集团 (Carl Zeiss Meditec AG.)、爱尔康、CorneaGen、Ziemer Ophthalmic Systems AG、RUMEX International Co. 等。
SKU-
Get online access to the report on the World's First Market Intelligence Cloud
- Interactive Data Analysis Dashboard
- Company Analysis Dashboard for high growth potential opportunities
- Research Analyst Access for customization & queries
- Competitor Analysis with Interactive dashboard
- Latest News, Updates & Trend analysis
- Harness the Power of Benchmark Analysis for Comprehensive Competitor Tracking
目录
1 INTRODUCTION
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 OVERVIEW OF THE EUROPE CORNEAL IMPLANTS MARKET
1.4 CURRENCY AND PRICING
1.5 LIMITATIONS
1.6 MARKETS COVERED
2 MARKET SEGMENTATION
2.1 MARKETS COVERED
2.2 GEOGRAPHICAL SCOPE
2.3 YEARS CONSIDERED FOR THE STUDY
2.4 DBMR TRIPOD DATA VALIDATION MODEL
2.5 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS
2.6 MULTIVARIATE MODELLING
2.7 MARKET END USER COVERAGE GRID
2.8 DBMR MARKET POSITION GRID
2.9 VENDOR SHARE ANALYSIS
2.1 SECONDARY SOURCES
2.11 ASSUMPTIONS
3 EXECUTIVE SUMMARY
4 PREMIUM INSIGHTS
4.1 PESTLE ANALYSIS
4.2 PORTERS FIVE FORCES ANALYSIS
5 EUROPE CORNEAL TRANSPLANT MARKET: REGULATIONS
5.1 REGULATORY AUTHORITIES IN THE ASIA-PACIFIC REGION
5.2 NORTH AMERICA REGULATORY SCENARIO
5.3 EUROPE REGULATORY SCENARIO
5.4 MIDDLE EAST AND AFRICA REGULATORY SCENARIO
5.5 SOUTH AMERICA REGULATORY SCENARIO
6 CUSTOMIZATION
7 MARKET OVERVIEW
7.1 DRIVERS
7.1.1 INCREASING PREVALENCE OF EYE DISEASES
7.1.2 RISING GERIATRIC POPULATION
7.1.3 TECHNOLOGICAL ADVANCEMENTS IN CORNEAL IMPLANTS
7.1.4 RISE IN MINIMALLY INVASIVE SURGERY IN CORNEAL TRANSPLANT
7.2 RESTRAINTS
7.2.1 HIGH COST ASSOCIATED WITH CORNEAL TRANSPLANT SURGERY
7.2.2 SHORTAGE OF DONORS IN CORNEAL TRANSPLANT
7.3 OPPORTUNITIES
7.3.1 RISE IN HEALTHCARE INFRASTRUCTURE
7.3.2 INCREASE IN PUBLIC AWARENESS AND EDUCATION
7.3.3 PARTNERSHIPS AND COLLABORATIONS ASSOCIATED WITH CORNEAL TRANSPLANTS
7.4 CHALLENGES
7.4.1 SURGICAL AND POST-SURGICAL COMPLICATIONS
7.4.2 LIMITED AWARENESS AND TRAINING
8 EUROPE CORNEAL TRANSPLANT MARKET, BY TYPE
8.1 OVERVIEW
8.2 HUMAN CORNEA
8.3 SYNTHETIC
9 EUROPE CORNEAL TRANSPLANT MARKET, BY PROCEDURE TYPE
9.1 OVERVIEW
9.2 ENDOTHELIAL KERATOPLASTY
9.2.1 DESCEMET'S MEMBRANE ENDOTHELIAL KERATOPLASTY (DMEK)
9.2.2 DESCEMET'S STRIPPING ENDOTHELIAL KERATOPLASTY(DSEK)/DESCEMET'S STRIPPING AUTOMATED ENDOTHELIAL KERATOPLASTY (DSAEK)
9.3 PENETRATING KERATOPLASTY
9.4 ANTERIOR LAMELLAR KERATOPLASTY (ALK)
9.4.1 DEEP ANTERIOR LAMELLAR KERATOPLASTY (DALK)
9.4.2 SUPERFICIAL ANTERIOR LAMELLAR KERATOPLASTY (SALK)
9.5 CORNEAL LIMBAL STEM CELL TRANSPLANT
9.6 ARTIFICIAL CORNEA TRANSPLANT
9.7 OTHERS
10 EUROPE CORNEAL TRANSPLANT MARKET, BY DONOR TYPE
10.1 OVERVIEW
10.2 ALLOGRAFT
10.3 AUTOGRAFT
11 EUROPE CORNEAL TRANSPLANT MARKET, BY INDICATION
11.1 OVERVIEW
11.2 FUCH'S ENDOTHELIAL DYSTROPHY
11.3 INFECTIOUS KERATITIS
11.4 BULLOUS KERATOPATHY
11.5 KERATOCONUS
11.6 REGRAFT PROCEDURES
11.7 CORNEAL SCARRING
11.8 CORNEAL ULCERS
11.9 OTHERS
12 EUROPE CORNEAL TRANSPLANT MARKET, BY GRAFT TYPE
12.1 OVERVIEW
12.2 PARTIAL THICKNESS GRAFTS (LAMELLAR)
12.2.1 DEEP LAMELLAR GRAFTS
12.2.2 SUPERFICIAL LAMELLAR GRAFTS
12.3 FULL THICKNESS GRAFTS (PENETRATING)
13 EUROPE CORNEAL TRANSPLANT MARKET, BY SURGERY TYPE
13.1 OVERVIEW
13.2 CONVENTIONAL SURGERY
13.3 LASER-ASSISTED SURGERY
14 EUROPE CORNEAL TRANSPLANT MARKET, BY GENDER
14.1 OVERVIEW
14.2 FEMALE
14.3 MALE
15 EUROPE CORNEAL TRANSPLANT MARKET, BY AGE GROUP
15.1 OVERVIEW
15.2 GERIATRIC
15.3 ADULT
15.4 PEDIATRIC
16 EUROPE CORNEAL TRANSPLANT MARKET, BY END USER
16.1 OVERVIEW
16.2 HOSPITALS
16.3 EYE CLINICS
16.4 AMBULATORY SURGICAL CENTERS
16.5 ACADEMIC & RESEARCH INSTITUTES
16.6 OTHERS
17 EUROPE CORNEAL TRANSPLANT MARKET, BY REGION
17.1 EUROPE
17.1.1 GERMANY
17.1.2 FRANCE
17.1.3 UK
17.1.4 SPAIN
17.1.5 ITALY
17.1.6 RUSSIA
17.1.7 SWITZERLAND
17.1.8 NETHERLANDS
17.1.9 TURKEY
17.1.10 BELGIUM
17.1.11 REST OF EUROPE
18 EUROPE CORNEAL TRANSPLANT MARKET: COMPANY LANDSCAPE
18.1 COMPANY SHARE ANALYSIS: EUROPE
19 SWOT ANALYSIS
20 COMPANY PROFILES
20.1 ZEISS GROUP (CARL ZEISS MEDITEC AG.)
20.1.1 COMPANY SNAPSHOT
20.1.2 REVENUE ANALYSIS
20.1.3 COMPANY SHARE ANALYSIS
20.1.4 PRODUCT PORTFOLIO
20.1.5 RECENT DEVELOPMENTS
20.2 ALCON
20.2.1 COMPANY SNAPSHOT
20.2.2 REVENUE ANALYSIS
20.2.3 COMPANY SHARE ANALYSIS
20.2.4 PRODUCT PORTFOLIO
20.2.5 RECENT DEVELOPMENT
20.3 CORNEAGEN
20.3.1 COMPANY SNAPSHOT
20.3.2 COMPANY SHARE ANALYSIS
20.3.3 PRODUCT PORTFOLIO
20.3.4 RECENT DEVELOPMENT
20.4 ZIEMER OPHTHALMIC SYSTEMS AG
20.4.1 COMPANY SNAPSHOT
20.4.2 COMPANY SHARE ANALYSIS
20.4.3 PRODUCT PORTFOLIO
20.4.4 RECENT DEVELOPMENT
20.5 RUMEX INTERNATIONAL CO.
20.5.1 COMPANY SNAPSHOT
20.5.2 COMPANY SHARE ANALYSIS
20.5.3 PRODUCT PORTFOLIO
20.5.4 RECENT DEVELOPMENT
20.6 AJL OPHTHALMIC S.A.
20.6.1 COMPANY SNAPSHOT
20.6.2 PRODUCT PORTFOLIO
20.6.3 RECENT DEVELOPMENT
20.7 CORNEAT VISION
20.7.1 COMPANY SNAPSHOT
20.7.2 PRODUCT PORTFOLIO
20.7.3 RECENT DEVELOPMENT
20.8 FLORIDA LIONS EYE BANK
20.8.1 COMPANY SNAPSHOT
20.8.2 PRODUCT PORTFOLIO
20.8.3 RECENT DEVELOPMENT
20.9 KERAMED, INC.
20.9.1 COMPANY SNAPSHOT
20.9.2 PRODUCT PORTFOLIO
20.9.3 RECENT DEVELOPMENT
20.1 MASSACHUSETTS EYE AND EAR
20.10.1 COMPANY SNAPSHOT
20.10.2 PRODUCT PORTFOLIO
20.10.3 RECENT DEVELOPMENT
20.11 OCL VISION
20.11.1 COMPANY SNAPSHOT
20.11.2 SERVICE PORTFOLIO
20.11.3 RECENT DEVELOPMENT
20.12 OVATION INTERNATIONAL
20.12.1 COMPANY SNAPSHOT
20.12.2 PRODUCT PORTFOLIO
20.12.3 RECENT DEVELOPMENT
20.13 SAN DIEGO EYE BANK
20.13.1 COMPANY SNAPSHOT
20.13.2 SERVICE PORTFOLIO
20.13.3 RECENT DEVELOPMENT
21 QUESTIONNAIRE
22 RELATED REPORTS
表格列表
TABLE 1 NUMBER OF CORNEAL TRANSPLANTS IN EACH COUNTRY, BY SURGERY TYPE
TABLE 2 NUMBER OF CORNEAL TRANSPLANTS IN EACH COUNTRY, BY INDICATION
TABLE 3 NUMBER OF CORNEAL TRANSPLANTS IN EACH COUNTRY, BY AGE
TABLE 4 NUMBER OF PATIENTS WAITING IN EACH COUNTRY
TABLE 5 NUMBER OF CORNEAL TRANSPLANTS IN EACH COUNTRY, BY DONOR TYPE
TABLE 6 PERCENTAGE OF HOSPITALS IN EACH COUNTRY WHERE CORNEAL TRANSPLANTS ARE PERFORMED (CLINICS OR HOSPITALS).
TABLE 7 AVERAGE COST FOR THE CORNEAL TRANSPLANT (PER/EYE) WITH RESPECT TO THE PROCEDURE TYPE IN ASIA-PACIFIC (INDIA)
TABLE 8 AVERAGE COST FOR THE CORNEAL TRANSPLANT WITH RESPECT TO THE PROCEDURE TYPE IN EUROPE
TABLE 9 AVERAGE COST FOR THE CORNEAL TRANSPLANT WITH RESPECT TO THE PROCEDURE TYPE IN SOUTH AMERICA
TABLE 10 EUROPE CORNEAL TRANSPLANT MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 11 EUROPE HUMAN CORNEA IN CORNEAL TRANSPLANT MARKET, BY REGION, 2022-2031 (USD THOUSAND)
TABLE 12 EUROPE SYNTHETIC IN CORNEAL TRANSPLANT MARKET, BY REGION, 2022-2031 (USD THOUSAND)
TABLE 13 EUROPE CORNEAL TRANSPLANT MARKET, BY PROCEDURE TYPE, 2022-2031 (USD THOUSAND)
TABLE 14 EUROPE ENDOTHELIAL KERATOPLASTY IN CORNEAL TRANSPLANT MARKET, BY REGION, 2022-2031 (USD THOUSAND)
TABLE 15 EUROPE ENDOTHELIAL KERATOPLASTY IN CORNEAL TRANSPLANT MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 16 EUROPE PENETRATING KERATOPLASTY IN CORNEAL TRANSPLANT MARKET, BY REGION, 2022-2031 (USD THOUSAND)
TABLE 17 EUROPE ANTERIOR LAMELLAR KERATOPLASTY (ALK) IN CORNEAL TRANSPLANT MARKET, BY REGION, 2022-2031 (USD THOUSAND)
TABLE 18 EUROPE ANTERIOR LAMELLAR KERATOPLASTY (ALK) IN CORNEAL TRANSPLANT MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 19 EUROPE CORNEAL LIMBAL STEM CELL TRANSPLANT IN CORNEAL TRANSPLANT MARKET, BY REGION, 2022-2031 (USD THOUSAND)
TABLE 20 EUROPE ARTIFICIAL CORNEA TRANSPLANT IN CORNEAL TRANSPLANT MARKET, BY REGION, 2022-2031 (USD THOUSAND)
TABLE 21 EUROPE OTHERS IN CORNEAL TRANSPLANT MARKET, BY REGION, 2022-2031 (USD THOUSAND)
TABLE 22 EUROPE CORNEAL TRANSPLANT MARKET, BY DONOR TYPE, 2022-2031 (USD THOUSAND)
TABLE 23 EUROPE ALLOGRAFT IN CORNEAL TRANSPLANT MARKET, BY REGION, 2022-2031 (USD THOUSAND)
TABLE 24 EUROPE ALLOGRAFT IN CORNEAL TRANSPLANT MARKET, BY REGION, 2022-2031 (USD THOUSAND)
TABLE 25 EUROPE CORNEAL TRANSPLANT MARKET, BY INDICATION, 2022-2031 (USD THOUSAND)
TABLE 26 EUROPE FUCH'S ENDOTHELIAL DYSTROPHY IN CORNEAL TRANSPLANT MARKET, BY REGION, 2022-2031 (USD THOUSAND)
TABLE 27 EUROPE INFECTIOUS KERATITIS IN CORNEAL TRANSPLANT MARKET, BY REGION, 2022-2031 (USD THOUSAND)
TABLE 28 EUROPE BULLOUS KERATOPATHY IN CORNEAL TRANSPLANT MARKET, BY REGION, 2022-2031 (USD THOUSAND)
TABLE 29 EUROPE KERATOCONUS IN CORNEAL TRANSPLANT MARKET, BY REGION, 2022-2031 (USD THOUSAND)
TABLE 30 EUROPE REGRAFT PROCEDURES IN CORNEAL TRANSPLANT MARKET, BY REGION, 2022-2031 (USD THOUSAND)
TABLE 31 EUROPE CORNEAL SCARRING IN CORNEAL TRANSPLANT MARKET, BY REGION, 2022-2031 (USD THOUSAND)
TABLE 32 EUROPE CORNEAL ULCERS IN CORNEAL TRANSPLANT MARKET, BY REGION, 2022-2031 (USD THOUSAND)
TABLE 33 EUROPE OTHERS IN CORNEAL TRANSPLANT MARKET, BY REGION, 2022-2031 (USD THOUSAND)
TABLE 34 EUROPE CORNEAL TRANSPLANT MARKET, BY GRAFT TYPE, 2022-2031 (USD THOUSAND)
TABLE 35 EUROPE PARTIAL THICKNESS GRAFTS (LAMELLAR) IN CORNEAL TRANSPLANT MARKET, BY REGION, 2022-2031 (USD THOUSAND)
TABLE 36 EUROPE PARTIAL THICKNESS GRAFTS (LAMELLAR) IN CORNEAL TRANSPLANT MARKET, BY GRAFT TYPE, 2022-2031 (USD THOUSAND)
TABLE 37 EUROPE FULL THICKNESS GRAFTS (PENETRATING) IN CORNEAL TRANSPLANT MARKET, BY REGION, 2022-2031 (USD THOUSAND)
TABLE 38 EUROPE CORNEAL TRANSPLANT MARKET, BY SURGERY TYPE, 2022-2031 (USD THOUSAND)
TABLE 39 EUROPE CONVENTIONAL SURGERY IN CORNEAL TRANSPLANT MARKET, BY REGION, 2022-2031 (USD THOUSAND)
TABLE 40 EUROPE LASER-ASSISTED SURGERY IN CORNEAL TRANSPLANT MARKET, BY REGION, 2022-2031 (USD THOUSAND)
TABLE 41 EUROPE CORNEAL TRANSPLANT MARKET, BY GENDER, 2022-2031 (USD THOUSAND)
TABLE 42 EUROPE FEMALE IN CORNEAL TRANSPLANT MARKET, BY REGION, 2022-2031 (USD THOUSAND)
TABLE 43 EUROPE MALE IN CORNEAL TRANSPLANT MARKET, BY REGION, 2022-2031 (USD THOUSAND)
TABLE 44 EUROPE CORNEAL TRANSPLANT MARKET, BY AGE GROUP, 2022-2031 (USD THOUSAND)
TABLE 45 EUROPE GERIATRIC IN CORNEAL TRANSPLANT MARKET, BY REGION, 2022-2031 (USD THOUSAND)
TABLE 46 EUROPE ADULT IN CORNEAL TRANSPLANT MARKET, BY REGION, 2022-2031 (USD THOUSAND)
TABLE 47 EUROPE PEDIATRIC IN CORNEAL TRANSPLANT MARKET, BY REGION, 2022-2031 (USD THOUSAND)
TABLE 48 EUROPE CORNEAL TRANSPLANT MARKET, BY END USER, 2022-2031 (USD THOUSAND)
TABLE 49 EUROPE HOSPITALS IN CORNEAL TRANSPLANT MARKET, BY REGION, 2022-2031 (USD THOUSAND)
TABLE 50 EUROPE EYE CLINICS IN CORNEAL TRANSPLANT MARKET, BY REGION, 2022-2031 (USD THOUSAND)
TABLE 51 EUROPE AMBULATORY SURGICAL CENTERS IN CORNEAL TRANSPLANT MARKET, BY REGION, 2022-2031 (USD THOUSAND)
TABLE 52 EUROPE ACADEMIC & RESEARCH INSTITUTES IN CORNEAL TRANSPLANT MARKET, BY REGION, 2022-2031 (USD THOUSAND)
TABLE 53 EUROPE OTHERS IN CORNEAL TRANSPLANT MARKET, BY REGION, 2022-2031 (USD THOUSAND)
TABLE 54 EUROPE CORNEAL TRANSPLANT MARKET, BY COUNTRY, 2022-2031 (USD THOUSAND)
TABLE 55 EUROPE CORNEAL TRANSPLANT MARKET, BY PROCEDURE TYPE, 2022-2031 (USD THOUSAND)
TABLE 56 EUROPE ENDOTHELIAL KERATOPLASTY IN CORNEAL TRANSPLANT MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 57 EUROPE ANTERIOR LAMELLAR KERATOPLASTY (ALK) IN CORNEAL TRANSPLANT MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 58 EUROPE CORNEAL TRANSPLANT MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 59 EUROPE CORNEAL TRANSPLANT MARKET, BY DONOR TYPE, 2022-2031 (USD THOUSAND)
TABLE 60 EUROPE CORNEAL TRANSPLANT MARKET, BY GRAFT TYPE, 2022-2031 (USD THOUSAND)
TABLE 61 EUROPE PARTIAL THICKNESS GRAFTS (LAMELLAR) IN CORNEAL TRANSPLANT MARKET, BY GRAFT TYPE, 2022-2031 (USD THOUSAND)
TABLE 62 EUROPE CORNEAL TRANSPLANT MARKET, BY SURGERY TYPE, 2022-2031 (USD THOUSAND)
TABLE 63 EUROPE CORNEAL TRANSPLANT MARKET, BY INDICATION, 2022-2031 (USD THOUSAND)
TABLE 64 EUROPE CORNEAL TRANSPLANT MARKET, BY GENDER, 2022-2031 (USD THOUSAND)
TABLE 65 EUROPE CORNEAL TRANSPLANT MARKET, BY AGE GROUP, 2022-2031 (USD THOUSAND)
TABLE 66 EUROPE CORNEAL TRANSPLANT MARKET, BY END USER, 2022-2031 (USD THOUSAND)
TABLE 67 GERMANY CORNEAL TRANSPLANT MARKET, BY PROCEDURE TYPE, 2022-2031 (USD THOUSAND)
TABLE 68 GERMANY ENDOTHELIAL KERATOPLASTY IN CORNEAL TRANSPLANT MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 69 GERMANY ANTERIOR LAMELLAR KERATOPLASTY (ALK) IN CORNEAL TRANSPLANT MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 70 GERMANY CORNEAL TRANSPLANT MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 71 GERMANY CORNEAL TRANSPLANT MARKET, BY DONOR TYPE, 2022-2031 (USD THOUSAND)
TABLE 72 GERMANY CORNEAL TRANSPLANT MARKET, BY GRAFT TYPE, 2022-2031 (USD THOUSAND)
TABLE 73 GERMANY PARTIAL THICKNESS GRAFTS (LAMELLAR) IN CORNEAL TRANSPLANT MARKET, BY GRAFT TYPE, 2022-2031 (USD THOUSAND)
TABLE 74 GERMANY CORNEAL TRANSPLANT MARKET, BY SURGERY TYPE, 2022-2031 (USD THOUSAND)
TABLE 75 GERMANY CORNEAL TRANSPLANT MARKET, BY INDICATION, 2022-2031 (USD THOUSAND)
TABLE 76 GERMANY CORNEAL TRANSPLANT MARKET, BY GENDER, 2022-2031 (USD THOUSAND)
TABLE 77 GERMANY CORNEAL TRANSPLANT MARKET, BY AGE GROUP, 2022-2031 (USD THOUSAND)
TABLE 78 GERMANY CORNEAL TRANSPLANT MARKET, BY END USER, 2022-2031 (USD THOUSAND)
TABLE 79 FRANCE CORNEAL TRANSPLANT MARKET, BY PROCEDURE TYPE, 2022-2031 (USD THOUSAND)
TABLE 80 FRANCE ENDOTHELIAL KERATOPLASTY IN CORNEAL TRANSPLANT MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 81 FRANCE ANTERIOR LAMELLAR KERATOPLASTY (ALK) IN CORNEAL TRANSPLANT MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 82 FRANCE CORNEAL TRANSPLANT MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 83 FRANCE CORNEAL TRANSPLANT MARKET, BY DONOR TYPE, 2022-2031 (USD THOUSAND)
TABLE 84 FRANCE CORNEAL TRANSPLANT MARKET, BY GRAFT TYPE, 2022-2031 (USD THOUSAND)
TABLE 85 FRANCE PARTIAL THICKNESS GRAFTS (LAMELLAR) IN CORNEAL TRANSPLANT MARKET, BY GRAFT TYPE, 2022-2031 (USD THOUSAND)
TABLE 86 FRANCE CORNEAL TRANSPLANT MARKET, BY SURGERY TYPE, 2022-2031 (USD THOUSAND)
TABLE 87 FRANCE CORNEAL TRANSPLANT MARKET, BY INDICATION, 2022-2031 (USD THOUSAND)
TABLE 88 FRANCE CORNEAL TRANSPLANT MARKET, BY GENDER, 2022-2031 (USD THOUSAND)
TABLE 89 FRANCE CORNEAL TRANSPLANT MARKET, BY AGE GROUP, 2022-2031 (USD THOUSAND)
TABLE 90 FRANCE CORNEAL TRANSPLANT MARKET, BY END USER, 2022-2031 (USD THOUSAND)
TABLE 91 UK CORNEAL TRANSPLANT MARKET, BY PROCEDURE TYPE, 2022-2031 (USD THOUSAND)
TABLE 92 UK ENDOTHELIAL KERATOPLASTY IN CORNEAL TRANSPLANT MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 93 UK ANTERIOR LAMELLAR KERATOPLASTY (ALK) IN CORNEAL TRANSPLANT MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 94 UK CORNEAL TRANSPLANT MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 95 UK CORNEAL TRANSPLANT MARKET, BY DONOR TYPE, 2022-2031 (USD THOUSAND)
TABLE 96 UK CORNEAL TRANSPLANT MARKET, BY GRAFT TYPE, 2022-2031 (USD THOUSAND)
TABLE 97 UK PARTIAL THICKNESS GRAFTS (LAMELLAR) IN CORNEAL TRANSPLANT MARKET, BY GRAFT TYPE, 2022-2031 (USD THOUSAND)
TABLE 98 UK CORNEAL TRANSPLANT MARKET, BY SURGERY TYPE, 2022-2031 (USD THOUSAND)
TABLE 99 UK CORNEAL TRANSPLANT MARKET, BY INDICATION, 2022-2031 (USD THOUSAND)
TABLE 100 UK CORNEAL TRANSPLANT MARKET, BY GENDER, 2022-2031 (USD THOUSAND)
TABLE 101 UK CORNEAL TRANSPLANT MARKET, BY AGE GROUP, 2022-2031 (USD THOUSAND)
TABLE 102 UK CORNEAL TRANSPLANT MARKET, BY END USER, 2022-2031 (USD THOUSAND)
TABLE 103 SPAIN CORNEAL TRANSPLANT MARKET, BY PROCEDURE TYPE, 2022-2031 (USD THOUSAND)
TABLE 104 SPAIN ENDOTHELIAL KERATOPLASTY IN CORNEAL TRANSPLANT MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 105 SPAIN ANTERIOR LAMELLAR KERATOPLASTY (ALK) IN CORNEAL TRANSPLANT MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 106 SPAIN CORNEAL TRANSPLANT MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 107 SPAIN CORNEAL TRANSPLANT MARKET, BY DONOR TYPE, 2022-2031 (USD THOUSAND)
TABLE 108 SPAIN CORNEAL TRANSPLANT MARKET, BY GRAFT TYPE, 2022-2031 (USD THOUSAND)
TABLE 109 SPAIN PARTIAL THICKNESS GRAFTS (LAMELLAR) IN CORNEAL TRANSPLANT MARKET, BY GRAFT TYPE, 2022-2031 (USD THOUSAND)
TABLE 110 SPAIN CORNEAL TRANSPLANT MARKET, BY SURGERY TYPE, 2022-2031 (USD THOUSAND)
TABLE 111 SPAIN CORNEAL TRANSPLANT MARKET, BY INDICATION, 2022-2031 (USD THOUSAND)
TABLE 112 SPAIN CORNEAL TRANSPLANT MARKET, BY GENDER, 2022-2031 (USD THOUSAND)
TABLE 113 SPAIN CORNEAL TRANSPLANT MARKET, BY AGE GROUP, 2022-2031 (USD THOUSAND)
TABLE 114 SPAIN CORNEAL TRANSPLANT MARKET, BY END USER, 2022-2031 (USD THOUSAND)
TABLE 115 ITALY CORNEAL TRANSPLANT MARKET, BY PROCEDURE TYPE, 2022-2031 (USD THOUSAND)
TABLE 116 ITALY ENDOTHELIAL KERATOPLASTY IN CORNEAL TRANSPLANT MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 117 ITALY ANTERIOR LAMELLAR KERATOPLASTY (ALK) IN CORNEAL TRANSPLANT MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 118 ITALY CORNEAL TRANSPLANT MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 119 ITALY CORNEAL TRANSPLANT MARKET, BY DONOR TYPE, 2022-2031 (USD THOUSAND)
TABLE 120 ITALY CORNEAL TRANSPLANT MARKET, BY GRAFT TYPE, 2022-2031 (USD THOUSAND)
TABLE 121 ITALY PARTIAL THICKNESS GRAFTS (LAMELLAR) IN CORNEAL TRANSPLANT MARKET, BY GRAFT TYPE, 2022-2031 (USD THOUSAND)
TABLE 122 ITALY CORNEAL TRANSPLANT MARKET, BY SURGERY TYPE, 2022-2031 (USD THOUSAND)
TABLE 123 ITALY CORNEAL TRANSPLANT MARKET, BY INDICATION, 2022-2031 (USD THOUSAND)
TABLE 124 ITALY CORNEAL TRANSPLANT MARKET, BY GENDER, 2022-2031 (USD THOUSAND)
TABLE 125 ITALY CORNEAL TRANSPLANT MARKET, BY AGE GROUP, 2022-2031 (USD THOUSAND)
TABLE 126 ITALY CORNEAL TRANSPLANT MARKET, BY END USER, 2022-2031 (USD THOUSAND)
TABLE 127 RUSSIA CORNEAL TRANSPLANT MARKET, BY PROCEDURE TYPE, 2022-2031 (USD THOUSAND)
TABLE 128 RUSSIA ENDOTHELIAL KERATOPLASTY IN CORNEAL TRANSPLANT MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 129 RUSSIA ANTERIOR LAMELLAR KERATOPLASTY (ALK) IN CORNEAL TRANSPLANT MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 130 RUSSIA CORNEAL TRANSPLANT MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 131 RUSSIA CORNEAL TRANSPLANT MARKET, BY DONOR TYPE, 2022-2031 (USD THOUSAND)
TABLE 132 RUSSIA CORNEAL TRANSPLANT MARKET, BY GRAFT TYPE, 2022-2031 (USD THOUSAND)
TABLE 133 RUSSIA PARTIAL THICKNESS GRAFTS (LAMELLAR) IN CORNEAL TRANSPLANT MARKET, BY GRAFT TYPE, 2022-2031 (USD THOUSAND)
TABLE 134 RUSSIA CORNEAL TRANSPLANT MARKET, BY SURGERY TYPE, 2022-2031 (USD THOUSAND)
TABLE 135 RUSSIA CORNEAL TRANSPLANT MARKET, BY INDICATION, 2022-2031 (USD THOUSAND)
TABLE 136 RUSSIA CORNEAL TRANSPLANT MARKET, BY GENDER, 2022-2031 (USD THOUSAND)
TABLE 137 RUSSIA CORNEAL TRANSPLANT MARKET, BY AGE GROUP, 2022-2031 (USD THOUSAND)
TABLE 138 RUSSIA CORNEAL TRANSPLANT MARKET, BY END USER, 2022-2031 (USD THOUSAND)
TABLE 139 SWITZERLAND CORNEAL TRANSPLANT MARKET, BY PROCEDURE TYPE, 2022-2031 (USD THOUSAND)
TABLE 140 SWITZERLAND ENDOTHELIAL KERATOPLASTY IN CORNEAL TRANSPLANT MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 141 SWITZERLAND ANTERIOR LAMELLAR KERATOPLASTY (ALK) IN CORNEAL TRANSPLANT MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 142 SWITZERLAND CORNEAL TRANSPLANT MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 143 SWITZERLAND CORNEAL TRANSPLANT MARKET, BY DONOR TYPE, 2022-2031 (USD THOUSAND)
TABLE 144 SWITZERLAND CORNEAL TRANSPLANT MARKET, BY GRAFT TYPE, 2022-2031 (USD THOUSAND)
TABLE 145 SWITZERLAND PARTIAL THICKNESS GRAFTS (LAMELLAR) IN CORNEAL TRANSPLANT MARKET, BY GRAFT TYPE, 2022-2031 (USD THOUSAND)
TABLE 146 SWITZERLAND CORNEAL TRANSPLANT MARKET, BY SURGERY TYPE, 2022-2031 (USD THOUSAND)
TABLE 147 SWITZERLAND CORNEAL TRANSPLANT MARKET, BY INDICATION, 2022-2031 (USD THOUSAND)
TABLE 148 SWITZERLAND CORNEAL TRANSPLANT MARKET, BY GENDER, 2022-2031 (USD THOUSAND)
TABLE 149 SWITZERLAND CORNEAL TRANSPLANT MARKET, BY AGE GROUP, 2022-2031 (USD THOUSAND)
TABLE 150 SWITZERLAND CORNEAL TRANSPLANT MARKET, BY END USER, 2022-2031 (USD THOUSAND)
TABLE 151 NETHERLANDS CORNEAL TRANSPLANT MARKET, BY PROCEDURE TYPE, 2022-2031 (USD THOUSAND)
TABLE 152 NETHERLANDS ENDOTHELIAL KERATOPLASTY IN CORNEAL TRANSPLANT MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 153 NETHERLANDS ANTERIOR LAMELLAR KERATOPLASTY (ALK) IN CORNEAL TRANSPLANT MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 154 NETHERLANDS CORNEAL TRANSPLANT MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 155 NETHERLANDS CORNEAL TRANSPLANT MARKET, BY DONOR TYPE, 2022-2031 (USD THOUSAND)
TABLE 156 NETHERLANDS CORNEAL TRANSPLANT MARKET, BY GRAFT TYPE, 2022-2031 (USD THOUSAND)
TABLE 157 NETHERLANDS PARTIAL THICKNESS GRAFTS (LAMELLAR) IN CORNEAL TRANSPLANT MARKET, BY GRAFT TYPE, 2022-2031 (USD THOUSAND)
TABLE 158 NETHERLANDS CORNEAL TRANSPLANT MARKET, BY SURGERY TYPE, 2022-2031 (USD THOUSAND)
TABLE 159 NETHERLANDS CORNEAL TRANSPLANT MARKET, BY INDICATION, 2022-2031 (USD THOUSAND)
TABLE 160 NETHERLANDS CORNEAL TRANSPLANT MARKET, BY GENDER, 2022-2031 (USD THOUSAND)
TABLE 161 NETHERLANDS CORNEAL TRANSPLANT MARKET, BY AGE GROUP, 2022-2031 (USD THOUSAND)
TABLE 162 NETHERLANDS CORNEAL TRANSPLANT MARKET, BY END USER, 2022-2031 (USD THOUSAND)
TABLE 163 TURKEY CORNEAL TRANSPLANT MARKET, BY PROCEDURE TYPE, 2022-2031 (USD THOUSAND)
TABLE 164 TURKEY ENDOTHELIAL KERATOPLASTY IN CORNEAL TRANSPLANT MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 165 TURKEY ANTERIOR LAMELLAR KERATOPLASTY (ALK) IN CORNEAL TRANSPLANT MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 166 TURKEY CORNEAL TRANSPLANT MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 167 TURKEY CORNEAL TRANSPLANT MARKET, BY DONOR TYPE, 2022-2031 (USD THOUSAND)
TABLE 168 TURKEY CORNEAL TRANSPLANT MARKET, BY GRAFT TYPE, 2022-2031 (USD THOUSAND)
TABLE 169 TURKEY PARTIAL THICKNESS GRAFTS (LAMELLAR) IN CORNEAL TRANSPLANT MARKET, BY GRAFT TYPE, 2022-2031 (USD THOUSAND)
TABLE 170 TURKEY CORNEAL TRANSPLANT MARKET, BY SURGERY TYPE, 2022-2031 (USD THOUSAND)
TABLE 171 TURKEY CORNEAL TRANSPLANT MARKET, BY INDICATION, 2022-2031 (USD THOUSAND)
TABLE 172 TURKEY CORNEAL TRANSPLANT MARKET, BY GENDER, 2022-2031 (USD THOUSAND)
TABLE 173 TURKEY CORNEAL TRANSPLANT MARKET, BY AGE GROUP, 2022-2031 (USD THOUSAND)
TABLE 174 TURKEY CORNEAL TRANSPLANT MARKET, BY END USER, 2022-2031 (USD THOUSAND)
TABLE 175 BELGIUM CORNEAL TRANSPLANT MARKET, BY PROCEDURE TYPE, 2022-2031 (USD THOUSAND)
TABLE 176 BELGIUM ENDOTHELIAL KERATOPLASTY IN CORNEAL TRANSPLANT MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 177 BELGIUM ANTERIOR LAMELLAR KERATOPLASTY (ALK) IN CORNEAL TRANSPLANT MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 178 BELGIUM CORNEAL TRANSPLANT MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 179 BELGIUM CORNEAL TRANSPLANT MARKET, BY DONOR TYPE, 2022-2031 (USD THOUSAND)
TABLE 180 BELGIUM CORNEAL TRANSPLANT MARKET, BY GRAFT TYPE, 2022-2031 (USD THOUSAND)
TABLE 181 BELGIUM PARTIAL THICKNESS GRAFTS (LAMELLAR) IN CORNEAL TRANSPLANT MARKET, BY GRAFT TYPE, 2022-2031 (USD THOUSAND)
TABLE 182 BELGIUM CORNEAL TRANSPLANT MARKET, BY SURGERY TYPE, 2022-2031 (USD THOUSAND)
TABLE 183 BELGIUM CORNEAL TRANSPLANT MARKET, BY INDICATION, 2022-2031 (USD THOUSAND)
TABLE 184 BELGIUM CORNEAL TRANSPLANT MARKET, BY GENDER, 2022-2031 (USD THOUSAND)
TABLE 185 BELGIUM CORNEAL TRANSPLANT MARKET, BY AGE GROUP, 2022-2031 (USD THOUSAND)
TABLE 186 BELGIUM CORNEAL TRANSPLANT MARKET, BY END USER, 2022-2031 (USD THOUSAND)
TABLE 187 REST OF EUROPE CORNEAL TRANSPLANT MARKET, BY PROCEDURE TYPE, 2022-2031 (USD THOUSAND)
图片列表
FIGURE 1 EUROPE CORNEAL TRANSPLANT MARKET: SEGMENTATION
FIGURE 2 EUROPE CORNEAL TRANSPLANT MARKET: DATA TRIANGULATION
FIGURE 3 EUROPE CORNEAL TRANSPLANT MARKET: DROC ANALYSIS
FIGURE 4 EUROPE CORNEAL TRANSPLANT MARKET: EUROPE VS REGIONAL MARKET ANALYSIS
FIGURE 5 EUROPE CORNEAL TRANSPLANT MARKET: COMPANY RESEARCH ANALYSIS
FIGURE 6 EUROPE CORNEAL TRANSPLANT MARKET: INTERVIEW DEMOGRAPHICS
FIGURE 7 EUROPE CORNEAL TRANSPLANT MARKET: MARKET END USER COVERAGE GRID
FIGURE 8 EUROPE CORNEAL TRANSPLANT MARKET: DBMR MARKET POSITION GRID
FIGURE 9 EUROPE CORNEAL TRANSPLANT MARKET: VENDOR SHARE ANALYSIS
FIGURE 10 EUROPE CORNEAL TRANSPLANT MARKET: SEGMENTATION
FIGURE 11 SIX SEGMENTS COMPRISE THE EUROPE CORNEAL TRANSPLANT MARKET, BY PROCEDURE TYPE
FIGURE 12 EXECUTIVE SUMMARY
FIGURE 13 STRATEGIC DECISIONS
FIGURE 14 INCREASING PREVALENCE OF EYE DISEASES IS DRIVING THE GROWTH OF THE EUROPE CORNEAL TRANSPLANT MARKET FROM 2024 TO 2031
FIGURE 15 THE ENDOTHELIAL KERATOPLASTY SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE EUROPE CORNEAL TRANSPLANT MARKET IN 2024 AND 2031
FIGURE 16 DROC ANALYSIS
FIGURE 17 EUROPE CORNEAL TRANSPLANT MARKET: BY TYPE, 2023
FIGURE 18 EUROPE CORNEAL TRANSPLANT MARKET: BY TYPE, 2024-2031 (USD THOUSAND)
FIGURE 19 EUROPE CORNEAL TRANSPLANT MARKET: TYPE, CAGR (2024-2031)
FIGURE 20 EUROPE CORNEAL TRANSPLANT MARKET: TYPE, LIFELINE CURVE
FIGURE 21 EUROPE CORNEAL TRANSPLANT MARKET: BY PROCEDURE TYPE, 2023
FIGURE 22 EUROPE CORNEAL TRANSPLANT MARKET: BY PROCEDURE TYPE, 2024-2031 (USD THOUSAND)
FIGURE 23 EUROPE CORNEAL TRANSPLANT MARKET: PROCEDURE TYPE, CAGR (2024-2031)
FIGURE 24 EUROPE CORNEAL TRANSPLANT MARKET: PROCEDURE TYPE, LIFELINE CURVE
FIGURE 25 EUROPE CORNEAL TRANSPLANT MARKET: BY DONOR TYPE, 2023
FIGURE 26 EUROPE CORNEAL TRANSPLANT MARKET: BY DONOR TYPE, 2024-2031 (USD THOUSAND)
FIGURE 27 EUROPE CORNEAL TRANSPLANT MARKET: DONOR TYPE, CAGR (2024-2031)
FIGURE 28 EUROPE CORNEAL TRANSPLANT MARKET: DONOR TYPE, LIFELINE CURVE
FIGURE 29 EUROPE CORNEAL TRANSPLANT MARKET: BY INDICATION, 2023
FIGURE 30 EUROPE CORNEAL TRANSPLANT MARKET: BY INDICATION, 2024-2031 (USD THOUSAND)
FIGURE 31 EUROPE CORNEAL TRANSPLANT MARKET: BY INDICATION, CAGR (2024-2031)
FIGURE 32 EUROPE CORNEAL TRANSPLANT MARKET: BY INDICATION, LIFELINE CURVE
FIGURE 33 EUROPE CORNEAL TRANSPLANT MARKET: BY GRAFT TYPE, 2023
FIGURE 34 EUROPE CORNEAL TRANSPLANT MARKET: BY GRAFT TYPE, 2024-2031 (USD THOUSAND)
FIGURE 35 EUROPE CORNEAL TRANSPLANT MARKET: BY GRAFT TYPE, CAGR (2024-2031)
FIGURE 36 EUROPE CORNEAL TRANSPLANT MARKET: BY GRAFT TYPE, LIFELINE CURVE
FIGURE 37 EUROPE CORNEAL TRANSPLANT MARKET: BY SURGERY TYPE, 2023
FIGURE 38 EUROPE CORNEAL TRANSPLANT MARKET: BY SURGERY TYPE, 2024-2031 (USD THOUSAND)
FIGURE 39 EUROPE CORNEAL TRANSPLANT MARKET: BY SURGERY TYPE, CAGR (2024-2031)
FIGURE 40 EUROPE CORNEAL TRANSPLANT MARKET: BY SURGERY TYPE, LIFELINE CURVE
FIGURE 41 EUROPE CORNEAL TRANSPLANT MARKET: BY GENDER, 2023
FIGURE 42 EUROPE CORNEAL TRANSPLANT MARKET: BY GENDER, 2024-2031 (USD THOUSAND)
FIGURE 43 EUROPE CORNEAL TRANSPLANT MARKET: BY GENDER, CAGR (2024-2031)
FIGURE 44 EUROPE CORNEAL TRANSPLANT MARKET: BY GENDER, LIFELINE CURVE
FIGURE 45 EUROPE CORNEAL TRANSPLANT MARKET: BY AGE GROUP, 2023
FIGURE 46 EUROPE CORNEAL TRANSPLANT MARKET: BY AGE GROUP, 2024-2031 (USD THOUSAND)
FIGURE 47 EUROPE CORNEAL TRANSPLANT MARKET: BY AGE GROUP, CAGR (2024-2031)
FIGURE 48 EUROPE CORNEAL TRANSPLANT MARKET: BY AGE GROUP, LIFELINE CURVE
FIGURE 49 EUROPE CORNEAL TRANSPLANT MARKET: BY END USER, 2023
FIGURE 50 EUROPE CORNEAL TRANSPLANT MARKET: BY END USER, 2024-2031 (USD THOUSAND)
FIGURE 51 EUROPE CORNEAL TRANSPLANT MARKET: BY END USER, CAGR (2024-2031)
FIGURE 52 EUROPE CORNEAL TRANSPLANT MARKET: BY END USER, LIFELINE CURVE
FIGURE 53 EUROPE CORNEAL TRANSPLANT MARKET: SNAPSHOT (2023)
FIGURE 54 EUROPE CORNEAL TRANSPLANT MARKET: COMPANY SHARE 2023 (%)
研究方法
Data collection and base year analysis are done using data collection modules with large sample sizes. The stage includes obtaining market information or related data through various sources and strategies. It includes examining and planning all the data acquired from the past in advance. It likewise envelops the examination of information inconsistencies seen across different information sources. The market data is analysed and estimated using market statistical and coherent models. Also, market share analysis and key trend analysis are the major success factors in the market report. To know more, please request an analyst call or drop down your inquiry.
The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market and primary (industry expert) validation. Data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Patent Analysis, Pricing Analysis, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.
可定制
Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Fact book) or can assist you in creating presentations from the data sets available in the report.
